News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

VertiFlex Completes Enrollment of the Superion® Pivotal IDE Clinical Trial



12/13/2011 1:44:11 PM

SAN CLEMENTE, Calif.--(BUSINESS WIRE)--VertiFlex®, Inc., a leading innovator of minimally invasive and motion preserving spinal surgery technologies, today announced the completion of enrollment in its pivotal IDE clinical trial of the Superion® Interspinous Spacer (ISS). The results of the Superion trial will form the basis for a PMA approval application to the U.S. Food and Drug Administration (FDA).

Read at BioSpace.com


comments powered by Disqus
VertiFlex
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES